Skip to content

Daily aspirin therapy linked to lower liver cancer risk

Image: carballo/Shutterstock.com

Hepatitis C testing linked to reduced opioid use among people who inject drugs

Hooman Farhang Zangneh presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Maviret cures most people with HCV genotype 3 and those with cirrhosis

Steven Flamm presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

HCV infection is rising among HIV-positive gay men in San Diego

Antoine Chaillon presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C cure leads to improved quality of life

Zobair Younossi presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

A year of generic PrEP could recoup its own cost within five years if effectiveness is high, Public Health England model finds

PrEP would save the NHS money, in numerous scenarios

Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers

MSM in London diagnosed with early syphilis are a priority group for PrEP, suggests UK study